CIMER
Registration Link
Search
Search results
268 results found
Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.
Tahir, Usman A, Daniel H Katz, Julian Avila-Pachecho, Alexander G Bick, Akhil Pampana, Jeremy M Robbins, Zhi Yu, et al. 2022. “Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.”. Nature Communications 13 (1): 4923.
Lp(a) in the Cath Lab: Opportunities for Refined Secondary…and Primary…Prevention of PAD?
Benson, Mark D. 2022. “Lp(a) in the Cath Lab: Opportunities for Refined Secondary…and Primary…Prevention of PAD?”. JACC. Cardiovascular Interventions 15 (14): 1477-79.
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program.
Plutzky, Jorge, Mark D Benson, Kira Chaney, Tiffany Bui V, Michael Kraft, Lina Matta, Marian McPartlin, et al. 2022. “Population Health Management of Low-Density Lipoprotein Cholesterol via a Remote, Algorithmic, Navigator-Executed Program.”. American Heart Journal 243: 15-27.
Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults.
Katz, Daniel H, Usman A Tahir, Debby Ngo, Mark D Benson, Yan Gao, Xu Shi, Matthew Nayor, et al. 2021. “Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults.”. Circulation. Genomic and Precision Medicine 14 (3): e003191.
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk.
Ngo, Debby, Mark D Benson, Jonathan Z Long, Zsu-Zsu Chen, Ruiqi Wang, Anjali K Nath, Michelle J Keyes, et al. 2021. “Proteomic Profiling Reveals Biomarkers and Pathways in Type 2 Diabetes Risk.”. JCI Insight 6 (5).
Emerging Affinity Reagents for High Throughput Proteomics: Trust, but Verify.
Benson, Mark D, Debby Ngo, Peter Ganz, and Robert E Gerszten. 2019. “Emerging Affinity Reagents for High Throughput Proteomics: Trust, But Verify.”. Circulation 140 (20): 1610-12.
Probing the Virtual Proteome to Identify Novel Disease Biomarkers.
Mosley, Jonathan D, Mark D Benson, Gustav Smith, Olle Melander, Debby Ngo, Christian M Shaffer, Jane F Ferguson, et al. 2018. “Probing the Virtual Proteome to Identify Novel Disease Biomarkers.”. Circulation 138 (22): 2469-81.
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
Ngo, Debby, Sumita Sinha, Dongxiao Shen, Eric W Kuhn, Michelle J Keyes, Xu Shi, Mark D Benson, et al. 2016. “Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.”. Circulation 134 (4): 270-85.
Beneficial metabolic effects of PAHSAs depend on the gut microbiota in diet-induced obese mice but not in chow-fed mice.
Lee, Jennifer, Kerry Wellenstein, Ali Rahnavard, Andrew T Nelson, Marlena M Holter, Bethany P Cummings, Vladimir Yeliseyev, et al. 2024. “Beneficial Metabolic Effects of PAHSAs Depend on the Gut Microbiota in Diet-Induced Obese Mice But Not in Chow-Fed Mice.”. Proceedings of the National Academy of Sciences of the United States of America 121 (28): e2318691121.